Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.

Gao, Feng; Huang, Gang; Xiao, Jiaqi

Gao, Feng; Huang, Gang; Xiao, Jiaqi.

Afiliación

Gao F; State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
Huang G; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Xiao J; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Med Res Rev ; 40(5): 2049-2084, 2020 09.

Article en En | MEDLINE | ID: mdl-32525247

Asunto(s)

Antineoplásicos; Chalcona; Chalconas; Neoplasias; Antineoplásicos/farmacología; Antineoplásicos/uso terapéutico; Chalcona/farmacología; Chalcona/uso terapéutico; Chalconas/farmacología; Chalconas/uso terapéutico; Humanos; Estructura Molecular; Neoplasias/tratamiento farmacológico; Relación Estructura-Actividad

Palabras clave

anticancer; chalcone; drug-resistant; hybrid compounds; mechanisms of action; structure-activity relationship

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Asunto principal: Chalcona / Chalconas / Neoplasias / Antineoplásicos Idioma: En Revista: Med Res Rev Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google